157 related articles for article (PubMed ID: 9550392)
21. Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions.
Amano S; Hazama F; Hamashima Y
Jpn Circ J; 1979 Aug; 43(8):741-8. PubMed ID: 41114
[TBL] [Abstract][Full Text] [Related]
22. Detection of auto-antibodies against a 70 kDa protein derived from vascular smooth muscle cells in patients with Kawasaki disease.
Suzuki H; Muragaki Y; Uemura S; Takeuchi T; Minami T; Shibuta S; Ohshima A; Yoshikawa N
Eur J Pediatr; 2002 Jun; 161(6):324-9. PubMed ID: 12029451
[TBL] [Abstract][Full Text] [Related]
23. Autoantibody production in Kawasaki syndrome.
Rider LG; Wener MH; French J; Sherry DD; Mendelman PM
Clin Exp Rheumatol; 1993; 11(4):445-9. PubMed ID: 8403592
[TBL] [Abstract][Full Text] [Related]
24. Kawasaki disease: infection, immunity and genetics.
Wang CL; Wu YT; Liu CA; Kuo HC; Yang KD
Pediatr Infect Dis J; 2005 Nov; 24(11):998-1004. PubMed ID: 16282937
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive determination of endothelial cell function in the microcirculation in Kawasaki syndrome.
Kurio GH; Zhiroff KA; Jih LJ; Fronek AS; Burns JC
Pediatr Cardiol; 2008 Jan; 29(1):121-5. PubMed ID: 17891433
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin-containing cells and the origin of immunoglobulins in the respiratory tract of sheep.
Scicchitano R; Husband AJ; Cripps AW
Immunology; 1984 Jul; 52(3):529-37. PubMed ID: 6540243
[TBL] [Abstract][Full Text] [Related]
27. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
Lue C; Tarkowski A; Mestecky J
J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993
[TBL] [Abstract][Full Text] [Related]
28. Antigenic recognition by intravenous gamma-globulin of selected bacteria isolated from throats of patients with Kawasaki syndrome.
Lekova ES; Joffe L; Glode MP
Pediatr Infect Dis J; 1990 Sep; 9(9):620-3. PubMed ID: 1700361
[TBL] [Abstract][Full Text] [Related]
29. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome).
Landing BH; Larson EJ
Am J Cardiovasc Pathol; 1987; 1(2):218-29. PubMed ID: 3333141
[TBL] [Abstract][Full Text] [Related]
30. Superantigens in Kawasaki syndrome.
Leung DY; Meissner HC; Fulton DR; Quimby F; Schlievert PM
Clin Immunol Immunopathol; 1995 Nov; 77(2):119-26. PubMed ID: 7586718
[TBL] [Abstract][Full Text] [Related]
31. Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease.
Doi M; Takeda T; Sakurai Y; Kato J; Hayashi T; Fukuda K; Takase T; Shima M
J Investig Allergol Clin Immunol; 2010; 20(5):413-8. PubMed ID: 20945608
[TBL] [Abstract][Full Text] [Related]
32. [Expression of monocyte chemotactic protein-1 in peripheral blood mononuclear cells of children with Kawasaki disease and its relation to coronary artery impairment].
Zhang J; Gui YH; Yang Y
Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):132-5. PubMed ID: 19099689
[TBL] [Abstract][Full Text] [Related]
33. Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study.
Falcini F; Ozen S; Magni-Manzoni S; Candelli M; Ricci L; Martini G; Cuttica RJ; Oliveira S; Calabri GB; Zulian F; Pistorio A; La Torre F; Rigante D
Clin Exp Rheumatol; 2012; 30(5):799-804. PubMed ID: 23020938
[TBL] [Abstract][Full Text] [Related]
34. Kawasaki syndrome and factors associated with coronary artery abnormalities in California.
Callinan LS; Tabnak F; Holman RC; Maddox RA; Kim JJ; Schonberger LB; Vugia DJ; Belay ED
Pediatr Infect Dis J; 2012 Sep; 31(9):894-8. PubMed ID: 22565293
[TBL] [Abstract][Full Text] [Related]
35. Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin.
Nonoyama S; Farrington M; Ishida H; Howard M; Ochs HD
J Clin Invest; 1993 Sep; 92(3):1282-7. PubMed ID: 7690775
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of interleukin-18 are elevated in the subacute phase of kawasaki syndrome.
Nomura Y; Masuda K; Maeno N; Yoshinaga M; Kawano Y
Int Arch Allergy Immunol; 2004 Oct; 135(2):161-5. PubMed ID: 15345916
[TBL] [Abstract][Full Text] [Related]
37. ITPKC susceptibility in Kawasaki syndrome as a sensitizing factor for autoimmunity and coronary arterial wall relaxation induced by thimerosal's effects on calcium signaling via IP3.
Yeter D; Deth R
Autoimmun Rev; 2012 Oct; 11(12):903-8. PubMed ID: 22498790
[TBL] [Abstract][Full Text] [Related]
38. [Kawasaki syndrome in an adult].
Hansen SK; Buhl MR
Ugeskr Laeger; 1998 Mar; 160(12):1807-8. PubMed ID: 9536639
[TBL] [Abstract][Full Text] [Related]
39. IgA Levels Are Associated with Coronary Artery Lesions in Kawasaki Disease.
Kim JJ; Kim HJ; Yu JJ; Yun SW; Lee KY; Yoon KL; Kil HR; Kim GB; Han MK; Song MS; Lee HD; Jun HO; Ha KS; Hong YM; Jang GY; Lee JK;
Korean Circ J; 2021 Mar; 51(3):267-278. PubMed ID: 33655727
[TBL] [Abstract][Full Text] [Related]
40. Conjunctival biopsy in patients with Kawasaki disease.
Burns JC; Wright JD; Newburger JW; Schneeberger EE; Mierau GW; Smith LE
Pediatr Pathol Lab Med; 1995; 15(4):547-53. PubMed ID: 8597841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
